NewsBenzingaWells Fargo mantiene su recomendación de sobreponderar sobre Valvoline y eleva el precio objetivo a 42 dólares Wells Fargo mantiene su recomendación de sobreponderar sobre Valvoline y eleva el precio objetivo a 42 dólares Benzinga 2026.11.20 15:35 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on California Resources, Raises Price Target to $77 B. Riley Securities Reiterates Buy on Orchestra BioMed Hldgs, Raises Price Target to $12 Wells Fargo Maintains Overweight on Crescent Energy, Raises Price Target to $22 Wells Fargo Maintains Overweight on Valvoline, Raises Price Target to $42 B. Riley Securities Maintains Buy on NioCorp Developments, Lowers Price Target to $8 Wells Fargo Maintains Equal-Weight on Ross Stores, Lowers Price Target to $215